surmount-1 tirzepatide non-diabetic obesity weight loss For the first time, and semaglutide were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults with obesity, no diabetes. 72 weeks. Both drugs at maximum tolerated dose. The Effect of Tirzepatide on Body
Description
You want 2.5 mg
For more information, check out the CardioNerds Journal Club Page
For more information, call 1-800-LillyRx (1-800-545-5979) or go to www.zepbound.lilly.com
The 10 mg dose is 100 units, which is the full capacity of a 1 mL syringe
Srinath R, Pedersen S, Neff L, et al
Frequently Asked Questions About Semaglutide and Tirzepatide Dosing Q: How do I know if my Semaglutide dose is working
00656-2/asset/38c98550-9ec2-44e8-ba6a-dbb815075666/main.assets/gr1_lrg.jpg)
